Latest Capital Raise News

LTR Pharma has increased its ownership in LevOmega to approximately 43% through a strategic A$1 million investment, reinforcing its commitment to sustainable, pharmaceutical-grade omega-3 development.

Vection Technologies secures a $7.8 million initial order under a $22.3 million multi-year framework with a NATO-approved European defence partner, reinforcing its role in the defence XR market.

Orion Minerals has increased its capital raising to A$8.6 million following additional commitments from sophisticated investors, signaling growing confidence in the company’s prospects.

The Takeovers Panel has declined to investigate allegations against Duxton Farms’ major shareholders concerning a recent merger and capital placement, affirming no change in control despite reduced voting power.

Aguia Resources has enhanced its capital raising by increasing free attaching options to one per new share in its $4 million entitlement issue, now open to shareholders in Australia, New Zealand, and Hong Kong.

Aguia Resources Limited has announced a non-renounceable entitlement issue to raise up to $4 million, offering new shares at 2.7 cents each alongside free options exercisable at 3.5 cents. The capital raise aims to fund key exploration projects in Brazil and Colombia.

Equity Story Group Ltd has had its trading suspension lifted immediately following a capital raising announcement, signaling renewed market activity for the financial services company.

Equity Story Group has raised $650,000 through a strategic convertible loan led by new Non-Executive Chair Alex Brinkmeyer, signaling a pivot into property funds management. The company also announced significant board changes, including the appointment of David Nolan as Managing Director.

Klevo Rewards Limited has extended the closing date of its entitlement offer to 15 October 2025, aiming to raise up to $4.12 million through a discounted share issue. This move provides shareholders additional time to participate in the company’s capital raising effort.

Artrya Limited has successfully completed a strongly supported Share Purchase Plan, raising approximately A$5 million despite significant oversubscription. This follows a recent $75 million placement, underscoring investor confidence in its AI-driven coronary artery disease platform.

Equity Story Group Ltd has voluntarily suspended trading of its shares pending a forthcoming announcement about a capital raise, signaling a significant funding event.

Unith Ltd reported an 18.8% increase in FY 2025 revenue to A$5.37 million alongside a significant capital raise, positioning itself for expansion in the burgeoning AI Digital Humans market.